These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36167720)
1. Efficacy of lycopene for management of oral potentially malignant disorders: A systematic review and meta-analysis. Al-Maweri SA; Halboub E; Al-Qadhi G; Al-Wesabi M; Al-Sharani HM; Parveen S; Alhashimi N; Almeslet A; Alhajj MN Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jan; 135(1):79-95. PubMed ID: 36167720 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials. Guo J; Xie H; Wu H; Liang M J Evid Based Dent Pract; 2020 Dec; 20(4):101471. PubMed ID: 33303091 [TBL] [Abstract][Full Text] [Related]
3. Impact of oral potentially malignant disorders on quality of life. Tadakamadla J; Kumar S; Lalloo R; Gandhi Babu DB; Johnson NW J Oral Pathol Med; 2018 Jan; 47(1):60-65. PubMed ID: 28766765 [TBL] [Abstract][Full Text] [Related]
4. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979 [TBL] [Abstract][Full Text] [Related]
5. An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis. Ahmad T; Khan I; Rizvi MM; Saalim M; Manzoor N; Sultana A Natl J Maxillofac Surg; 2021; 12(3):316-323. PubMed ID: 35153425 [TBL] [Abstract][Full Text] [Related]
6. Drug treatment for oral submucous fibrosis: an update. Chen X; Xie H; Guo J BMC Oral Health; 2023 Oct; 23(1):748. PubMed ID: 37828490 [TBL] [Abstract][Full Text] [Related]
7. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. Rai B; Kaur J; Jacobs R; Singh J J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949 [TBL] [Abstract][Full Text] [Related]
8. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study. Sudha VM; Hemavathy S Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045 [TBL] [Abstract][Full Text] [Related]
9. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial. Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913 [TBL] [Abstract][Full Text] [Related]
10. Curcumin in the treatment of oral submucous fibrosis: a systematic review and meta-analysis of randomized controlled trials. Shao Y; Miao J; Wang Y Int J Oral Maxillofac Surg; 2024 Mar; 53(3):239-250. PubMed ID: 38057194 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials. Guo J; Xie H; Mao S; Liang M; Wu H J Oral Pathol Med; 2020 Apr; 49(4):311-319. PubMed ID: 32145110 [TBL] [Abstract][Full Text] [Related]
12. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Malignant Transformation of Oral Leukoplakia and Oral Lichen Planus Using Laser: An Observational Study. Arora KS; Bansal R; Mohapatra S; Verma A; Sharma S; Pareek S Asian Pac J Cancer Prev; 2018 Dec; 19(12):3635-3641. PubMed ID: 30583693 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review. Agha-Hosseini F; Sheykhbahaei N; SadrZadeh-Afshar MS J Contemp Dent Pract; 2016 Aug; 17(8):692-701. PubMed ID: 27659090 [TBL] [Abstract][Full Text] [Related]
15. Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial. Piyush P; Mahajan A; Singh K; Ghosh S; Gupta S Oral Dis; 2019 Jan; 25(1):73-79. PubMed ID: 30059188 [TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study. Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials. Al-Maweri SA Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Apr; 127(4):300-308. PubMed ID: 30745280 [TBL] [Abstract][Full Text] [Related]
18. Antioxidant treatments in patients with oral submucous fibrosis: A systematic review. Pérez-Leal M; Lanciano F; Flacco N; Estornut C; Carceller MC J Oral Pathol Med; 2024 Jan; 53(1):31-41. PubMed ID: 38155549 [TBL] [Abstract][Full Text] [Related]
19. Lycopene in the management of oral lichen planus: a placebo-controlled study. Saawarn N; Shashikanth MC; Saawarn S; Jirge V; Chaitanya NC; Pinakapani R Indian J Dent Res; 2011; 22(5):639-43. PubMed ID: 22406705 [TBL] [Abstract][Full Text] [Related]
20. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. Sun SL; Liu JJ; Zhong B; Wang JK; Jin X; Xu H; Yin FY; Liu TN; Chen QM; Zeng X Br J Dermatol; 2019 Dec; 181(6):1166-1176. PubMed ID: 30903622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]